Collectively, these findings suggest that EESP can suppress the production of TNF-α, IFN-γ, IL-6, and MCP-1 and consequently inhibit epidermal hyperplasia, hyperkeratosis, and immune cell infiltration, which ameliorate the skin symptoms of CD and suppress skin-thickening. The gene discussed is IFNG; the disease is Hyperkeratosis.